News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Acrux Limited to Push on with Phase 3 Testosterone Trial
July 18, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Australian biotech Acrux Ltd will push ahead with phase III trials of its male testosterone replacement therapy, following the success of a recent US study.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
Australia
MORE ON THIS TOPIC
Cancer
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
September 1, 2026
·
2 min read
·
Annalee Armstrong
Vaccines
GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modality
September 1, 2026
·
1 min read
·
Heather McKenzie
CAR-T
Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events
September 1, 2026
·
3 min read
·
Tristan Manalac
Cardiovascular disease
Arrowhead’s new Redemplo findings in severe hypertriglyceridemia have analysts split
August 31, 2026
·
3 min read
·
Tristan Manalac
